INTERNATIONAL PATENT: VAXCELL-BIO CO., LTD., 주식회사 박셀바이오, INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY, 전남대학교산학협력단 FILES APPLICATION FOR "HYDROPHILIC MONOBODY HAVING IMPROVED PROPERTIES TARGETING EPHA2 AND MULTISPECIFIC CHIMERIC ANTIGEN RECEPTOR AND ENGINEERED IMMUNE CELL COMPRISING SAME"

GENEVA, May 19 -- VAXCELL-BIO CO., LTD. (12-55 Sandan-gil, Hwasun-eupHwasun-gunJeollanam-do 58141), 주식회사 박셀바이오 (전라남도화순군화순읍 산단길 12-55), INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (77 Yongbong-roBuk-guGwangju 61186), 전남대학교산학협력단 (광주광역시북구용봉로 77) filed a patent application (PCT/KR2024/017519) for "HYDROPHILIC MONOBODY HAVING IMPROVED PROPERTIES TARGETING EPHA2 AND MULTISPECIFIC CHIMERIC ANTIGEN RECEPTOR AND ENGINEERED IMMUNE CELL COMPRISING SAME" on...